RRRamona Rath

Ramona Rath

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ramona Rath has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Andreas Hecker

    Department of General, Visceral, Thoracic and Transplant Surgery, University Hospital Giessen, Justus-Liebig-University Giessen, Rudolf-Buchheim-Strasse 6, 35392 Giessen, Germany

    1 shared publication
  • Christian Koch

    Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, University Hospital of Giessen and Marburg, Rudolf-Buchheim-Strasse 7, 35392 Giessen, Germany

    1 shared publication
  • Emmanuel Schneck

    Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Gießen und Marburg (UKGM), Justus-Liebig-Universität Gießen, Gießen, Deutschland

    1 shared publication
  • Ingolf Askevold

    Department of General, Visceral, Thoracic and Transplant Surgery, University Hospital Giessen, Justus-Liebig-University Giessen, Rudolf-Buchheim-Strasse 6, 35392 Giessen, Germany

    1 shared publication
  • Konstantin Mayer

    Department of Pulmonology and Sleep Medicine ViDia Clinics Karlsruhe Germany

    1 shared publication
  • Martin Reichert

    Department of General, Visceral, Thoracic, and Transplant Surgery, Giessen University Hospital, Justus-Liebig-University of Giessen, Giessen, Germany

    1 shared publication

Latest Publications

  • Open Access

    Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients

    by Emmanuel Schneck, Ingolf Askevold, Ramona Rath, Andreas Hecker, Martin Reichert, Stefan Guth, Christian Koch, Michael Sander, Werner Seeger, Konstantin Mayer, et al.

    Chronic Lung Allograft Dysfunction (CLAD) is a life-threatening complication that limits the long-term survival of lung transplantation patients. Early diagnosis remains the basis of efficient management of CLAD, making the need for distinctive biomarkers critical. This explorative study aimed to investigate the predictive power of mitochondrial DNA (mtDNA) derived from bronchoalveolar lavages (BAL) to detect CLAD. The study included 106 lung transplant recipients and analyzed 286 BAL samples for cell count, cell differentiation, and inflammatory and mitochondrial biomarkers, including mtDNA. A receiver operating curve analysis of mtDNA levels was used to assess its ability to detect CLAD. The results revealed a discriminatory pro-inflammatory cytokine profile in the BAL fluid of CLAD patients. The concentration of mtDNA increased in step with each CLAD stage, reaching its highest concentration in stage 4, and correlated significantly with decreasing FEV1. The receiver operating curve analysis of mtDNA in BAL revealed a moderate prediction of CLAD when all stages were grouped together (AUROC 0.75, p-value < 0.0001). This study has found the concentration mtDNA in BAL to be a potential predictor for the early detection of CLAD and the differentiation of different CLAD stages, independent of the underlying pathology.